CA
NZ
UK
AU
IND
US
SanDisk Corp. (NASDAQ:SNDK) fell 13.64% on June 23, 2026, but the session's decline must be understood against the backdrop of one of the most remarkable equity re-ratings in recent market history: a near 5,000% surge since the company's February 2025 spinoff from Western Digital.
SK Hynix's remarkable ascent to surpass Samsung Electronics in memory semiconductor market capitalisation, driven by its commanding lead in HBM3E high-bandwidth memory production, provided essential context for understanding the severity of South Korea's June 23 market rout.
The semiconductor equipment sector declined approximately 8% on June 23, 2026, one of its sharpest single-session corrections of the year, as a combination of Korean memory market contagion and AI capital spending concerns created a broad risk-off event across all segments of the chip …
Sanuwave Health Inc., a commercial-stage medical device company focused on ultrasound wound care technology, declined on June 23, 2026, as a broad macro risk-off event weighed on all small-cap growth categories including medical devices.
SanDisk Corp. (NASDAQ:SNDK) fell 13.64% to close at $1,960 on June 23, 2026, as a combination of Korean memory sector contagion and renewed valuation scrutiny triggered broad profit-taking in one of the year's most spectacular performers.
The Indian rupee came under depreciation pressure in the first half of 2026 as a combination of Federal Reserve hawkishness, global risk-off conditions, and domestic macro factors created headwinds for emerging market currencies including the rupee.
QuickLogic Corporation (NASDAQ:QUIK) declined on June 23, 2026, as a broad semiconductor sector selloff extended to small-cap programmable logic and embedded AI chip companies.
Hyperliquid Strategies Inc. (NASDAQ:PURR), formerly known as Sonnet BioTherapeutics before its corporate pivot to a digital asset treasury strategy, declined on June 23, 2026, as broad risk-off conditions reduced investor appetite for cryptocurrency-correlated equities alongside technology and growth stocks.
Polyrizon Ltd. (NASDAQ:PLRZ), an Israeli clinical-stage biopharmaceutical company developing bio-adhesive nasal gel drug delivery technology, declined on June 23, 2026, as broad small-cap biotech selling extended to clinical-stage names across all geographies and disease areas.
The artificial intelligence data centre buildout has created an unprecedented demand environment for photonic integrated circuits, driving a wave of investment, production ramp-up, and new entrant activity across the optical networking supply chain even as the June 23, 2026, selloff temporarily compressed valuations across …
Please wait processing your request...